⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Pomerantz LLP Alerts Shareholders to Investor Suit Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
globenewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Urged to Join Class Action Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
REGN Deadline Alert: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of Securities Class Action Deadline on September 14, 2026
globenewswire.com
REGN
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
REGN
Cancer Monoclonal Antibodies Market Size & Share Analysis | Growth Trends and Forecasts (2026- 2031) | Covers Five Global Regions
globenewswire.com
BMY
LLY
AMGN
PFE
GSK
REGN
ABBV
SEIC
JNJ
AZN
MRK
WSE UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Wise Group plc (WSE) Investors of Securities Class Action Lawsuit Deadline on September 29, 2026 Ready to Announce with Confidence?
newsfilecorp.com
WSE
REGN
RXT
REGN UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
September 14, 2026 Deadline Approaching: Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky
accessnewswire.com
REGN
Pomerantz LLP Highlights Class Action Filing Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN